Startseite Omega-3 fatty acid for the treatment and remission of Crohn’s disease
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Omega-3 fatty acid for the treatment and remission of Crohn’s disease

  • Katharine Swan EMAIL logo und Pat J. Allen
Veröffentlicht/Copyright: 24. Mai 2013

Abstract: This integrative literature review focused on the use of omega-3 fatty acid supplementation for the treatment of Crohn’s disease (CD). A systematic review of studies investigating the use of omega-3 in individuals with CD was performed. OVID MEDLINE, the Cochrane Database, and CINAHL were searched for pertinent research. Experiments were limited to double-blind placebo controlled trials. Five studies observing CD relapse rates and three studies examining biochemical changes were evaluated. The studies reviewed show contradicting information regarding the efficacy of omega-3 for CD. While some studies have shown supplementation with omega-3 results in sustained remission from disease, other studies concluded no correlation between omega-3 supplementation and improved remission rates. Studies investigating biochemical variables suggest favorable changes in immunological milieu, including modifications of lipid profiles and cytokine production. The studies reviewed are adversely limited by low number of participants, short duration of study and other significant deficits. Limited data remain available and current literature indicated mixed conclusions regarding the efficacy of omega-3 for treatment of CD. Further large-scale studies of longer duration are necessary.

References

1. Crohn’s and Colitis Foundation of America. About Crohn’s disease, 2009. Available at: http://www.ccfa.org/info/about/crohns. Accessed January2011.Suche in Google Scholar

2. Peyrin-BirouletL, LoftusEV, ColombelJ.SandbornWJ. The natural history of adult crohn’s disease in population-based cohorts. Am J Gastroenterol2010;105:28997.10.1038/ajg.2009.579Suche in Google Scholar PubMed

3. Pinetonde Chambrun G, Peyrin-BirouletL, LemannM, ColobelJ. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroeneterol Hepatol2010;7:1529.10.1038/nrgastro.2009.203Suche in Google Scholar PubMed

4. Van AsscheG, VermeireS, RutgeertsP. Immunosuppression in inflammatory bowel disease: Traditional, biological or both?Curr Opin Gastroeneterol2009;25:3238.10.1097/MOG.0b013e32832c073aSuche in Google Scholar PubMed

5. KemperKJ, VohraS, WallsR. The use of complementary and alternative medicine in pediatrics. Pediatrics2008;122(6):137486.10.1542/peds.2008-2173Suche in Google Scholar PubMed

6. HasanSS, AhmedSI, BukhariNI, LoonWC. Use of complementary and alternative medicine among patients with chronic disease at outpatient clinics. Complement Ther Clin Pract2009;15(3):1527.10.1016/j.ctcp.2009.02.003Suche in Google Scholar PubMed

7. WoolfAD. Herbal remedies and children: do they work? Are they harmful?Pediatrics2003;112(1):2406.10.1542/peds.112.S1.240Suche in Google Scholar

8. National Center for Complementary and Alternative Medicine (NCCAM). The use of complementary and alternative medicine in the United States, 2008. Available at: http://nccam.nih.gov/news/camstats/2007/camsurvey_fs1.htm. Accessed October2010.Suche in Google Scholar

9. MacDonaldA. Omega-3 fatty acids as adjunctive therapy in Crohns disease. Gastroenterol Nurs2006;29(4):295301.10.1097/00001610-200607000-00005Suche in Google Scholar PubMed

10. RuggieroC, LattanzioF, LaurentaniF, GasperiniB, Andres-LacuevaC, CherubiniA. Omega-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis. Curr Pharm Des2009;15:413548.10.2174/138161209789909746Suche in Google Scholar PubMed

11. KremerJM, LawrenceDA, PetrilloGF, LittsLL, MullalyPM, RynesRI, et al.. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs clinical and immune correlates. Arthritis Rheum1995;38(8):110714.10.1002/art.1780380813Suche in Google Scholar PubMed

12. CalderP. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res2007;52:88597.10.1002/mnfr.200700289Suche in Google Scholar PubMed

13. TurnerD, ZlotkinSH, ShahPS, GriffithsAM. Omega 3 fatty acids (fish oil) for maintenance of remission in crohn’s disease. Cochrane Database Syst Rev2009;1:114.10.1002/14651858.CD006320.pub3Suche in Google Scholar PubMed

14. BelluzziA, BrignolaC, CampieriM, PeraA, BoschiS, MiglioliM. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Eng J Med1996;334(24):155760.10.1056/NEJM199606133342401Suche in Google Scholar

15. BestWR, BecktelJM, SingletonJ, KernF. Development of a Crohn’s disease activity index: national cooperative Crohn’s disease study. Gastroenterology1976;70(3):43944.10.1016/S0016-5085(76)80163-1Suche in Google Scholar

16. Lorenz-MeyerH, BauerP, NicolayC, SchulzB, PurrmannJ, FleigWE, et al.. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn’s disease. A randomized controlled multicenter trial. Study Group Members (German Crohn’s Disease Study Group). Scand J Gastroenterol1996;31(8) 77885.10.3109/00365529609010352Suche in Google Scholar PubMed

17. RomanoC, CucchiaraS, BarabinoA, AnneseV, SferlazzasC. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn’s disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol2005;11:711821.10.3748/wjg.v11.i45.7118Suche in Google Scholar PubMed PubMed Central

18. FeaganBG, SandbornWJ, MittmannU, Bar-MeirS, D’HaensG, BradetteM, et al.. Omega-3 free fatty acids for the maintenance of remission in crohn disease: the EPIC randomized controlled trials. JAMA2008;299:16907.10.1001/jama.299.14.1690Suche in Google Scholar

19. GeerlingBJ, Badart-SmookA, van DeursenC, van HouwelingenAC, RussellMG, StockbruggerRW, et al.. Nutritional supplementation with N-3 fatty acids and antioxidants in individuals with Crohn’s disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis2000; 6(2):7784.10.1097/00054725-200005000-00002Suche in Google Scholar PubMed

20. NielsenAA, JorgensenLG, NielsenJN, EivindsonM, GronbaekH, VindI, et al.. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in individuals with active Crohn’s disease compared with omega-6 fatty acids. Aliment Pharmacol Ther2005;22(1112):11218.10.1111/j.1365-2036.2005.02698.xSuche in Google Scholar PubMed

21. TrebbleTM, ArdenN.K, WoottonSA, CalderPC, MulleeMA, FineDA, et al.. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr2004;80:113744.10.1093/ajcn/80.5.1137Suche in Google Scholar PubMed

22. PhillipsonBE, RothrockDW, ConnerWE, HarrisWS, IllingworthDR. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglycerinemia. N Eng J Med1985;312:12106.10.1056/NEJM198505093121902Suche in Google Scholar PubMed

23. AndersonGD, LynnAM. Optimizing pediatric dosing: a developmental pharmacologic approach. Pharmacotherapy2009;29(6):68090.10.1592/phco.29.6.680Suche in Google Scholar PubMed

24. CalderP. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids2008;79:35.10.1016/j.plefa.2008.09.016Suche in Google Scholar PubMed

25. SekiH, TaniY, AritaM. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat2009;89:12630.10.1016/j.prostaglandins.2009.03.002Suche in Google Scholar PubMed

26. MassaroM, ScodittiE, CarluccioMA, CampanaMC, De CaterinaR. Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oil. Cell Mol Biol2010;56(1):5982.Suche in Google Scholar

27. BittonA, DobkinPL, EdwardesMD, SewitchMJ, MeddingsJB, RawalS, et al.. Predicting relapse in Crohn’s disease: a biopsychosocial model. Gut2008;57:138692.10.1136/gut.2007.134817Suche in Google Scholar PubMed

Received: 2011-08-19
Accepted: 2012-07-18
Published Online: 2013-05-24

©2013 by Walter de Gruyter Berlin / Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Phytochemistry & Product Quality
  4. Chemical and pharmacological standardization of Ashwagandhadi lehyam: an ayurvedic formulation
  5. Phytochemical screening and toxicity studies on the methanol extract of the seeds of moringa oleifera
  6. First report of fingerprinting dried herbal products using a subtractive diversity array
  7. Preclinical Studies
  8. Antidiabetic and antihypertensive effect of Virgin Argan Oil in model of neonatal streptozotocin-induced diabetic and l-nitroarginine methylester (l-NAME) hypertensive rats
  9. Hypoglycemic activity of the Anisopus mannii N. E. Br. methanolic leaf extract in normal and alloxan-induced diabetic mice
  10. Aloe vera gel protects liver from oxidative stress-induced damage in experimental rat model
  11. Hepatoprotective activity of Calotropis gigantea flowers against carbon-tetrachloride-induced liver damage in mice
  12. In vivo and in vitro estrogenic activity of extracts from Erythrina poeppigiana (Fabaceae)
  13. Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (Histone Deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson’s disease: implications for epigenetics-based nanotechnology-driven drug platform
  14. Antimalarial potential of China 30 and Chelidonium 30 in combination therapy against lethal rodent malaria parasite: Plasmodium berghei
  15. Structure elucidation and inhibitory effects on human platelet aggregation of chlorogenic acid from Wrightia tinctoria
  16. Cytotoxic effects of crocin on MOLT-4 human leukemia cells
  17. Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines
  18. Tea toxicity and cholinesterase inhibition of Huilliche herbal medicine
  19. Iatrogenic venous thrombosis secondary to supplemental medicine toxicity
  20. Clinical Studies
  21. Decreasing cardiovascular risk factors in obese individuals using a combination of PGX® meal replacements and PGX® granules in a 12-week clinical weight modification program
  22. The use of an anti-inflammatory supplement in patients with chronic kidney disease
  23. Impact of relaxation training according to the Yoga In Daily Life® system on anxiety after breast cancer surgery
  24. Positive impact of Tai Chi Chuan participation on biopsychosocial quality of life compared to exercise and sedentary controls: a cross-sectional survey
  25. Using a standardized Viniyoga protocol for lung cancer survivors: a pilot study examining effects on breathing ease
  26. Research utilization and evidence-based practice among Saskatchewan massage therapists
  27. Laser acupuncture in treatment of childhood bronchial asthma
  28. Case Reports
  29. Developing an in-patient acupuncture treatment in a pediatric hospital
  30. Reviews & Perspectives
  31. Is yoga an effective treatment in the management of patients with chronic low back pain compared with other care modalities – a systematic review
  32. Omega-3 fatty acid for the treatment and remission of Crohn’s disease
  33. Any role for probiotics in the therapy or prevention of autoimmune diseases? Up-to-date review
  34. Hericium erinaceus: an edible mushroom with medicinal values
  35. Are conduits superconductor-like and supported by tetrahedra structure of hyaluronic matrix in living systems? New perspectives
Heruntergeladen am 1.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jcim-2012-0010/pdf
Button zum nach oben scrollen